These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7589883)

  • 1. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Naoumova R; Slavin BM; Thompson GR; Sönksen PH
    Diabetologia; 1995 Aug; 38(8):959-67. PubMed ID: 7589883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Kelly JM; Jackson NC; Sönksen PH
    Diabetes; 1995 Sep; 44(9):1059-65. PubMed ID: 7657029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.
    Naoumova RP; Cummings MH; Watts GF; Rendell NB; Taylor GW; Sönksen PH; Thompson GR
    Eur J Clin Invest; 1996 Apr; 26(4):332-40. PubMed ID: 8732493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: a stable isotope study.
    Cummings MH; Watts GF; Pal C; Umpleby M; Hennessy TR; Naoumova R; Sönksen PH
    Clin Sci (Lond); 1995 Feb; 88(2):225-33. PubMed ID: 7720348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of insulin on cholesterol synthesis in type II diabetes patients.
    Scoppola A; Testa G; Frontoni S; Maddaloni E; Gambardella S; Menzinger G; Lala A
    Diabetes Care; 1995 Oct; 18(10):1362-9. PubMed ID: 8721938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study.
    Christ ER; Cummings MH; Albany E; Umpleby AM; Lumb PJ; Wierzbicki AS; Naoumova RP; Boroujerdi MA; Sönksen PH; Russell-Jones DL
    J Clin Endocrinol Metab; 1999 Jan; 84(1):307-16. PubMed ID: 9920100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of Troglitazone in patients with diet-controlled type 2 diabetes.
    Robinson AC; Jeffs JA; Gray RG; Bannister PA; Mather H; Gallagher JJ; Robinson S; Nattrass M; Venkatesan S; Halliday D; Johnston DG
    Eur J Clin Invest; 2004 Jan; 34(1):29-36. PubMed ID: 14984435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
    Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
    Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypopituitarsim is associated with triglyceride enrichment of very low-density lipoprotein.
    Kearney T; Navas de Gallegos C; Chrisoulidou A; Gray R; Bannister P; Venkatesan S; Johnston DG
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3900-6. PubMed ID: 11502830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
    Cusi K; Cunningham GR; Comstock JP
    Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinally derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia.
    Curtin A; Deegan P; Owens D; Collins P; Johnson A; Tomkin GH
    Acta Diabetol; 1995 Dec; 32(4):244-50. PubMed ID: 8750763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
    Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
    Diabetologia; 1997 Apr; 40(4):454-62. PubMed ID: 9112023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation.
    Rivellese A; Riccardi G; Romano G; Giacco R; Patti L; Marotta G; Annuzzi G; Mancini M
    Diabetologia; 1988 Dec; 31(12):884-8. PubMed ID: 3240843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
    al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
    Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein abnormalities in well-treated type II diabetic patients.
    Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
    Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
    Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
    Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
    Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
    Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.